Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403126 · ClinicalTrials.gov registry record · NA
To Increase Psychological Well-being by the Implementation of Forgiveness Education
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 1,300
- Enrollment target
NCT04403126: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT04403126 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,300 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403126, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,300 participants
- Enrollment target
Study Summary
This project examines the development of psychological well-being in children and teachers through a 12- week forgiveness education program conducted in three conflict zones of the world, Northern Ireland, Israel/Palestine, and Taiwan. A 12-week forgiveness education program will be investigated in elementary schools in three conflict zones of the world, Northern Ireland, Israel/Palestine, and Taiwan. The responsibilities of the sub-team in each of the three research sites will be: * a. recruiting schools, assisting the teacher training before the forgiveness education program starts * b. shepherding teachers, doing the fidelity checks, administering the instruments and collecting data during the forgiveness education program. Once a school gives permission to be part of this study, the forgiveness curriculum will be implemented as a 12-week standard curriculum for the grade 5 (US equivalency) students. Teachers of the grade 5 classes will be trained to administer the program. Teachers, students and their parents must give the consent to take part in the measures of the study.
Primary Outcome
Enright Forgiveness Inventory Short Form (EFI-30), scores range from 30 to 180 with higher scores representing higher levels of forgiveness, which is a better outcome.
Interventions
- OTHER forgiveness education intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2021-09-03 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT04403126 record still lists
NCT04403126 is an interventional study that assigns participants to a tested intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which forgiveness education intervention is the first listed.
NCT04403126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04403126 about?
NCT04403126 is a clinical study titled "To Increase Psychological Well-being by the Implementation of Forgiveness Education". This project examines the development of psychological well-being in children and teachers through a 12- week forgiveness education program conducted in three conflict zones of the world, Northern Ireland, Israel/Palestine, and Taiwan. A 12-week forgiveness education program will be investigated in...
What is the current status of trial NCT04403126?
This trial is currently completed. It is a NA study. The enrollment target is 1,300 participants. The study started on 2021-09-03. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT04403126?
The interventions under investigation include: forgiveness education intervention (OTHER).
Who is sponsoring clinical trial NCT04403126?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04403126's enrollment target sits among peer trials
1,300 76th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI